Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00055367
What this trial is testing

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07295834
What this trial is testing

Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial

Who this might be right for
Crohn Disease (CD)Ulcerative Colitis (UC)Fatigue
Imperial College London 70
Not applicableWithdrawnNCT04349449
What this trial is testing

ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice

Who this might be right for
Crohn Disease
Takeda
Early research (Phase 1)UnknownNCT01874015
What this trial is testing

Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease

Who this might be right for
Crohn's Disease
Royan Institute 10
Large-scale testing (Phase 3)Ended earlyNCT03627091
What this trial is testing

Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)

Who this might be right for
Crohn's Disease
Shire 40
Large-scale testing (Phase 3)Study completedNCT01235689
What this trial is testing

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 252
Large-scale testing (Phase 3)Study completedNCT00427921
What this trial is testing

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

Who this might be right for
Crohn's Disease
Abbott 304
Testing effectiveness (Phase 2)WithdrawnNCT00179842
What this trial is testing

Immune Ablation and Stem Cell Support for Crohn's Disease

Who this might be right for
Crohn Disease
Ann & Robert H Lurie Children's Hospital of Chicago
Not applicableUnknownNCT02088944
What this trial is testing

A Single-center Registered Clinical Research of Chinese Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Serological C Reactive Protein or Erythrocyte Sedimentation Rate
Nanfang Hospital, Southern Medical University 142
Large-scale testing (Phase 3)Active Not RecruitingNCT03466411
What this trial is testing

The Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 1,409
Testing effectiveness (Phase 2)Study completedNCT00102921
What this trial is testing

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Amgen 70
Large-scale testing (Phase 3)Study completedNCT04397263
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohns Disease
Janssen Pharmaceutical K.K. 38
Testing effectiveness (Phase 2)Study completedNCT01393899
What this trial is testing

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

Who this might be right for
Crohn's Disease
Pfizer 180
Large-scale testing (Phase 3)Ended earlyNCT05470985
What this trial is testing

Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Who this might be right for
Crohn Disease
Bristol-Myers Squibb 5
Large-scale testing (Phase 3)Study completedNCT02425111
What this trial is testing

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 101
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Not applicableStudy completedNCT06589895
What this trial is testing

Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study

Who this might be right for
Inflammatory Bowel Diseases
Centre Hospitalier Universitaire de Nīmes 40
Testing effectiveness (Phase 2)Study completedNCT00042055
What this trial is testing

CP-461 for the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Astellas Pharma Inc 30
Not applicableStudy completedNCT02033408
What this trial is testing

Manipulating the Microbiome in IBD by Antibiotics and FMT

Who this might be right for
Exacerbation of Ulcerative ColitisUlcerative Colitis, Active SevereCrohn's Colitis
Shaare Zedek Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT03677648
What this trial is testing

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Reistone Biopharma Company Limited 112
Next Page